Jayshree Chemicals Limited

Financial Results

JAYSHREE CHEMICALS LIMITED
Registered Office: Jayshree-761025, Dist-Ganjam(Orissa)
Please click to see Unaudited Financial Financial Report for quarter ended 30th September,2012Click Here
Please click to see Unaudited Financial Financial Report for quarter ended 30th June,2011Click Here
Please click to see Unaudited Financial Results for Three Months Ended 30th September,2011Click Here
Please click to see Unaudited Financial Results for Three Months Ended 31th December,2011Click Here
Please click to see Unaudited Financial Results for the Querter ended 30th June,2012Click Here
Audited Financial Results for the year ended 31st March, 2011
			(Rs. in Lacs)
	STANDALONE		CONSOLIDATED
PARTICULARS	Year Ended	Year Ended	Year Ended	Year Ended
	31/03/2011	31/03/2010	31/03/2011	31/03/2010
	(Audited)	(Audited)	(Audited)	(Audited)
	1	2	3	4
1. (a) Net Sales/Income from Operations	2888	4609	2888	4609
(b) Other Operating Income	21	37	21	34
	2909	4646	2909	4643
2. Expenditures
(a) (Increase)/decrease in stock in trade and work in progress	135	(78)	135	(78)
(b) Consumption of raw materials	393	637	393	637
(c) Purchase of traded goods	-	-	-	-
(d) Employees cost	591	656	591	656
(e) Depreciation	145	143	145	143
(f) Other expenditure
(i) Power & Fuel	1841	2054	1841	2054
(ii) Others	461	493	461	493
(g) Total	3566	3905	3566	3906
3. Profit from operations before Other Income,
Interest & Exceptional Items (1 - 2)	(657)	741	(657)	737
4. Other Income	879	27	880	30
5. Profit before Interest & Exceptional Items (3 + 4)	222	768	223	767
6. Interest	80	37	80	37
7. Profit after Interest but before Exceptional Items (5 - 6)	142	731	143	730
8. Exceptional Items	-	-	-	-
9. Profit (+)/Loss (-) from Ordinary Activities beforetax (7 + 8)	142	731	143	730
10. Tax Expenses
(a) Current Tax	28	(78)	135	(78)
(b) Fringe Benefit Tax	393	637	393	637
(c) Deferred Tax (Net)	-	-	-	-
(d) MAT Credit Entitlement	591	656	591	656
(e) Income Tax for earlier years	145	143	145	143
Total Tax	34	258	34	258
11. Net Profit (+)/Loss (-) from Ordinary Activities after tax (9 - 10)	108	473	1093	472
12. Extraordinary Item (Net of tax expenses Rs….)	-	-	-	-
13. Net Profit (+)/Loss (-) for the period (11 - 12)	108	473	109	472
14. Paid-up equity share capital (Face value - Rs. 10/- each)	2933	2933	2933	2933
15. Reserves excluding revaluation reserves asper balance sheet of previous accounting year.	2189	2082	2193	2085
16. Earnings per share(EPS)
a) Basic & Diluted EPS before extraordinary items for the period, for the year to date and for the previous year (not annualised)	0.37	7.14	0.37	7.13
b) Basic & Diluted EPS after extraordinaryitems for the period, for the year to date andfor the previous year (not annualised)	0.37	7.14	0.37	7.13
17. Public Shareholding	14983198	2450380	14983198	2450380
Number of Shares	15008198	14983198	15008198	14983198
Percentage of shareholding	51.176	51.091	51.176	51.091
18. Promoters and promoter group Shareholding **
a) Pledged/Encumbered	-	-	-	-
i)Number of shares	-	-	-	-
ii)Percentage of shares (as a % of the total shareholding of promoter and promoter group)	-	-	-	-
iv)Percentage of shares (as a % of the total share capital of the company)	-	-	-	-
b) Non-encumbered
Number of shares	14318259	14343259	14318259	14343259
Percentage of shares (as a % of the total shareholding of promoter and promoter group)	100.00	100.00	100.00	100.00
Percentage of shares (as a % of the total share capital of the company)	48.824	48.909	48.824	48.909
Segment wise Revenue, Results and Capital Employed alongwith the Audited Financial Results

			(Rs. in Lacs)
	STANDALONE		CONSOLIDATED
PARTICULARS	Year Ended	Year Ended	Year Ended	Year Ended
	31/03/2011	31/03/2010	31/03/2011	31/03/2010
	(Audited)	(Audited)	(Audited)	(Audited)
	1	2	3	4
1. Segment Revenue ( Net Sale/Income )
(a) Segment - Chemicals	2795	4594	2795	4594
(b) Segment -Wind Power	93	15	93	15
(c) Segment - Other	-	-	-	-
Total	2888	4609	2888	4609
Less: Inter Segment Revenue	-	-	-	-
Net Sales/Income from Operations	2888	4609	2888	4609
2. Segment Results (Profit) (+) / (-) [Before tax and interest from each segment]
(a) Segment - Chemicals	183	770	183	770
(b) Segment - Wind Power	52	(2)	52	(2)
(c) Segment - Other	(13)	-	(13)	-
Total	222	768	222	768
Less: Interest	80	37	80	37
Total Profit Before Tax	142	731	142	731
3. Capital Employed ( Segment Assets - Segment Liabilities)
(a) Segment - Chemicals	14822	1221	14822	1221
(b) Segment - Wind Power	674	653	674	653
(c) Segment - Other	1	-	1	-
Total	15497	1874	15497	1874

NOTE: 1. The above audited Financial Results were reviewed by the Audit Committee and approved by the Board of directors of the Company at their Meetings held on 30th May, 2011.
2. No complaint was received and lying unresolved by the Company from any investor during the period January, 2011 to March, 2011.
3. The Company commenced trial run of its new Membrane Cell technology based plant on 29th December, 2010, which was completed on 31st March, 2011.
4. Net Sales does not include Rs. 1561 lacs arising during the trial run of its new Plant which has been adjusted with Pre-operative Expenses.
5. Statement of Assets & Liabilities as on 31st March, 2011 is as under :-

			(Rs. in Lacs)
	STANDALONE		CONSOLIDATED
PARTICULARS	As at	As at	As at	As at
	31/03/2011	31/03/2010	31/03/2011	31/03/2010
	(Audited)	(Audited)	(Audited)	(Audited)
Shareholders' Fund
(a) Capital	2933	2933	2933	2933
(b) Reserves and Surplus	2189	2082	2193	2085
Minority Interest	-	-	-	-
Loan Funds	-	-	-	-
(a) Secured Loans	9198	3283	9198	3283
(b) Unsecured Loans	1175	-	1175	-
Deferred Tax Liability (Net)	323	358	323	358
	15818	8656	15827	8664
Net Fixed Assets( Including Capital WIP)	15662	4168	15662	4168
INVESTMENT	60	60	-	-
Current Assets, Loans & Advances
(a) Inventories	422	408	422	408
(b) Sundry Debtors	1107	636	1107	636
(c) Cash and Bank Balances	246	4003	252	4012
(d) Loans and Advances	1838	607	1838	606
Less: CURRENT LIABILITIES AND PROVISIONS
(a) Liabilities	3357	1157	3357	1157
(b) Provisions	160	69	160	70
MISCLLANEOUS EXPENSES ( To the extent not written off)	-	-	63	61
	15818	8656	15827	8664

6. Previous year's figures are regrouped and rearranged wherever necessary.